Direct-to-consumer genotyping: are we ready for a brave new world?

[...] interpretation of results, particularly those associated with risk assessment, presymptomatic disorders, and right-to-know issues with at-risk family members, can be problematic. Some DTCG companies, such as Pathway Genomics, have a chief privacy officer and complex computer systems with state...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical chemistry (Baltimore, Md.) Md.), 2010-07, Vol.56 (7), p.1056-1060
Hauptverfasser: Bender, Lew, Silverman, Lawrence M, Dinulos, Mary Beth, Nickel, Jim, Grody, Wayne W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1060
container_issue 7
container_start_page 1056
container_title Clinical chemistry (Baltimore, Md.)
container_volume 56
creator Bender, Lew
Silverman, Lawrence M
Dinulos, Mary Beth
Nickel, Jim
Grody, Wayne W
description [...] interpretation of results, particularly those associated with risk assessment, presymptomatic disorders, and right-to-know issues with at-risk family members, can be problematic. Some DTCG companies, such as Pathway Genomics, have a chief privacy officer and complex computer systems with state-of-the-art privacy protection, as well as computer programs that are frequently updated with the latest interpretations of testing results. Should individuals be free to request, from the privacy of their own homes and without any involvement of a healthcare professional, their own thyroid hormone levels, liver enzymes, prostatespecific antigen, and even serum troponin to determine if they have recently experienced a heart attack?
doi_str_mv 10.1373/clinchem.2009.138743
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733310269</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733310269</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-4b7cc56270895e98b69a2fc903d75a84b7742eb4cd7c7880edeaae7ecc1efc6d3</originalsourceid><addsrcrecordid>eNpdkE9LAzEQxYMotla_gUjw4mk12WQ3iRfR-hcKXvQcstnZumV3U5NdS7-9KW09CAPDzHvzGH4InVNyTZlgN7apO_sF7XVKiIorKTg7QGOaMZLILKeHaEyikijKxQidhLCIIxcyP0ajlGSU8oyO0cNj7cH2Se8S67owtODxHDrXr5d1N7_FxgNeAfZgyjWunMcGF978AO5ghVfON-XdKTqqTBPgbNcn6PP56WP6mszeX96m97PEMqH6hBfC2ixPBZEqAyWLXJm0soqwUmRGRlnwFApuS2GFlARKMAYEWEuhsnnJJuhqm7v07nuA0Ou2DhaaxnTghqAFY4ySNFfRefnPuXCD7-JzOicszWPRaOJbk_UuBA-VXvq6NX6tKdEbwnpPWG8I6y3heHaxyx6KFsq_oz1S9gvgsXiK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>603263261</pqid></control><display><type>article</type><title>Direct-to-consumer genotyping: are we ready for a brave new world?</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Bender, Lew ; Silverman, Lawrence M ; Dinulos, Mary Beth ; Nickel, Jim ; Grody, Wayne W</creator><creatorcontrib>Bender, Lew ; Silverman, Lawrence M ; Dinulos, Mary Beth ; Nickel, Jim ; Grody, Wayne W</creatorcontrib><description>[...] interpretation of results, particularly those associated with risk assessment, presymptomatic disorders, and right-to-know issues with at-risk family members, can be problematic. Some DTCG companies, such as Pathway Genomics, have a chief privacy officer and complex computer systems with state-of-the-art privacy protection, as well as computer programs that are frequently updated with the latest interpretations of testing results. Should individuals be free to request, from the privacy of their own homes and without any involvement of a healthcare professional, their own thyroid hormone levels, liver enzymes, prostatespecific antigen, and even serum troponin to determine if they have recently experienced a heart attack?</description><identifier>ISSN: 0009-9147</identifier><identifier>EISSN: 1530-8561</identifier><identifier>DOI: 10.1373/clinchem.2009.138743</identifier><identifier>PMID: 20511451</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Chief privacy officers ; Community Participation ; Electronic health records ; Genetic counseling ; Genetic Information Nondiscrimination Act 2008-US ; Genetic Testing ; Genetics ; Genotype ; Health facilities ; Health Insurance Portability &amp; Accountability Act 1996-US ; Humans ; Internet ; Precision Medicine ; Regulation ; Risk assessment ; Thyroid</subject><ispartof>Clinical chemistry (Baltimore, Md.), 2010-07, Vol.56 (7), p.1056-1060</ispartof><rights>Copyright American Association for Clinical Chemistry Jul 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c379t-4b7cc56270895e98b69a2fc903d75a84b7742eb4cd7c7880edeaae7ecc1efc6d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20511451$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bender, Lew</creatorcontrib><creatorcontrib>Silverman, Lawrence M</creatorcontrib><creatorcontrib>Dinulos, Mary Beth</creatorcontrib><creatorcontrib>Nickel, Jim</creatorcontrib><creatorcontrib>Grody, Wayne W</creatorcontrib><title>Direct-to-consumer genotyping: are we ready for a brave new world?</title><title>Clinical chemistry (Baltimore, Md.)</title><addtitle>Clin Chem</addtitle><description>[...] interpretation of results, particularly those associated with risk assessment, presymptomatic disorders, and right-to-know issues with at-risk family members, can be problematic. Some DTCG companies, such as Pathway Genomics, have a chief privacy officer and complex computer systems with state-of-the-art privacy protection, as well as computer programs that are frequently updated with the latest interpretations of testing results. Should individuals be free to request, from the privacy of their own homes and without any involvement of a healthcare professional, their own thyroid hormone levels, liver enzymes, prostatespecific antigen, and even serum troponin to determine if they have recently experienced a heart attack?</description><subject>Chief privacy officers</subject><subject>Community Participation</subject><subject>Electronic health records</subject><subject>Genetic counseling</subject><subject>Genetic Information Nondiscrimination Act 2008-US</subject><subject>Genetic Testing</subject><subject>Genetics</subject><subject>Genotype</subject><subject>Health facilities</subject><subject>Health Insurance Portability &amp; Accountability Act 1996-US</subject><subject>Humans</subject><subject>Internet</subject><subject>Precision Medicine</subject><subject>Regulation</subject><subject>Risk assessment</subject><subject>Thyroid</subject><issn>0009-9147</issn><issn>1530-8561</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkE9LAzEQxYMotla_gUjw4mk12WQ3iRfR-hcKXvQcstnZumV3U5NdS7-9KW09CAPDzHvzGH4InVNyTZlgN7apO_sF7XVKiIorKTg7QGOaMZLILKeHaEyikijKxQidhLCIIxcyP0ajlGSU8oyO0cNj7cH2Se8S67owtODxHDrXr5d1N7_FxgNeAfZgyjWunMcGF978AO5ghVfON-XdKTqqTBPgbNcn6PP56WP6mszeX96m97PEMqH6hBfC2ixPBZEqAyWLXJm0soqwUmRGRlnwFApuS2GFlARKMAYEWEuhsnnJJuhqm7v07nuA0Ou2DhaaxnTghqAFY4ySNFfRefnPuXCD7-JzOicszWPRaOJbk_UuBA-VXvq6NX6tKdEbwnpPWG8I6y3heHaxyx6KFsq_oz1S9gvgsXiK</recordid><startdate>201007</startdate><enddate>201007</enddate><creator>Bender, Lew</creator><creator>Silverman, Lawrence M</creator><creator>Dinulos, Mary Beth</creator><creator>Nickel, Jim</creator><creator>Grody, Wayne W</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4U-</scope><scope>7QO</scope><scope>7RV</scope><scope>7TM</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PCBAR</scope><scope>PDBOC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>201007</creationdate><title>Direct-to-consumer genotyping: are we ready for a brave new world?</title><author>Bender, Lew ; Silverman, Lawrence M ; Dinulos, Mary Beth ; Nickel, Jim ; Grody, Wayne W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-4b7cc56270895e98b69a2fc903d75a84b7742eb4cd7c7880edeaae7ecc1efc6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Chief privacy officers</topic><topic>Community Participation</topic><topic>Electronic health records</topic><topic>Genetic counseling</topic><topic>Genetic Information Nondiscrimination Act 2008-US</topic><topic>Genetic Testing</topic><topic>Genetics</topic><topic>Genotype</topic><topic>Health facilities</topic><topic>Health Insurance Portability &amp; Accountability Act 1996-US</topic><topic>Humans</topic><topic>Internet</topic><topic>Precision Medicine</topic><topic>Regulation</topic><topic>Risk assessment</topic><topic>Thyroid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bender, Lew</creatorcontrib><creatorcontrib>Silverman, Lawrence M</creatorcontrib><creatorcontrib>Dinulos, Mary Beth</creatorcontrib><creatorcontrib>Nickel, Jim</creatorcontrib><creatorcontrib>Grody, Wayne W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric &amp; Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Earth, Atmospheric &amp; Aquatic Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bender, Lew</au><au>Silverman, Lawrence M</au><au>Dinulos, Mary Beth</au><au>Nickel, Jim</au><au>Grody, Wayne W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct-to-consumer genotyping: are we ready for a brave new world?</atitle><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle><addtitle>Clin Chem</addtitle><date>2010-07</date><risdate>2010</risdate><volume>56</volume><issue>7</issue><spage>1056</spage><epage>1060</epage><pages>1056-1060</pages><issn>0009-9147</issn><eissn>1530-8561</eissn><abstract>[...] interpretation of results, particularly those associated with risk assessment, presymptomatic disorders, and right-to-know issues with at-risk family members, can be problematic. Some DTCG companies, such as Pathway Genomics, have a chief privacy officer and complex computer systems with state-of-the-art privacy protection, as well as computer programs that are frequently updated with the latest interpretations of testing results. Should individuals be free to request, from the privacy of their own homes and without any involvement of a healthcare professional, their own thyroid hormone levels, liver enzymes, prostatespecific antigen, and even serum troponin to determine if they have recently experienced a heart attack?</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>20511451</pmid><doi>10.1373/clinchem.2009.138743</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-9147
ispartof Clinical chemistry (Baltimore, Md.), 2010-07, Vol.56 (7), p.1056-1060
issn 0009-9147
1530-8561
language eng
recordid cdi_proquest_miscellaneous_733310269
source MEDLINE; Oxford University Press Journals All Titles (1996-Current)
subjects Chief privacy officers
Community Participation
Electronic health records
Genetic counseling
Genetic Information Nondiscrimination Act 2008-US
Genetic Testing
Genetics
Genotype
Health facilities
Health Insurance Portability & Accountability Act 1996-US
Humans
Internet
Precision Medicine
Regulation
Risk assessment
Thyroid
title Direct-to-consumer genotyping: are we ready for a brave new world?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T20%3A38%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct-to-consumer%20genotyping:%20are%20we%20ready%20for%20a%20brave%20new%20world?&rft.jtitle=Clinical%20chemistry%20(Baltimore,%20Md.)&rft.au=Bender,%20Lew&rft.date=2010-07&rft.volume=56&rft.issue=7&rft.spage=1056&rft.epage=1060&rft.pages=1056-1060&rft.issn=0009-9147&rft.eissn=1530-8561&rft_id=info:doi/10.1373/clinchem.2009.138743&rft_dat=%3Cproquest_cross%3E733310269%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=603263261&rft_id=info:pmid/20511451&rfr_iscdi=true